Nuvectis Pharma, Inc. (NVCT) vs Verastem, Inc. (VSTM)
Nuvectis Pharma, Inc. and Verastem, Inc. are both Biotechnology companies. Nuvectis Pharma, Inc. and Verastem, Inc. are of similar size ($706.1M and $694.6M). Nuvectis Pharma, Inc. has the higher net margin (0.00% vs −231.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Nuvectis Pharma, Inc. leads on 7 and Verastem, Inc. on 5.
Valuation
Profitability
| Metric | NVCT | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 86.35% | 65.16% |
| Operating margin | 0.00% | (182.57%) | 0.00% |
| Net margin | 0.00% | (231.59%) | 0.00% |
| Free cash flow margin | 0.00% | (185.31%) | 0.00% |
| Return on equity | (233.30%) | (471.16%) | (57.72%) |
| Return on assets | (122.61%) | (100.65%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack